Apr. 26 at 4:20 AM
$OGN
For clarity, there was no Sun and OGN deal which ‘fell through’, as some believe.
On January 20, 2026 the Economic Times (India) published an article which claimed Sun Pharma was working with financial interests to pull together between
$10 -
$14 Billion in funding and had made a ‘non-binding offer’ for OGN.
As expected, Sun Pharma called the article and possible bid for OGN ‘speculative in nature’ and there were no legal material requirements which require any disclosures from them.
In other words…Sun was pulling funds together and was browsing. Anything else is headlines to gain story clicks.
Sun had probably not even started doing any Due Diligence back in January.
Then on April 10, 2026 another article appeared in India’s Economic Times, stating Sun had made a non-binding, all-cash offer of
$12 Billion for OGN.
Once again, Sun Pharma called the possible bid for OGN ‘speculative in nature’. They will not confirm the bidding / buying until it has been been generally completed.
